Abstract
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an increasingly used technique by the interventional pulmonologist in lung cancer staging and diagnosis of both malignant and benign mediastinal lymphadenopathy amongst other applications. There are increasing data to support the use of EBUS-TBNA over mediastinoscopy as a first staging or diagnostic procedure in defined situations. In this review, the technique of EBUS-TBNA is briefly discussed with a more extended discussion around comparative studies of mediastinal staging techniques, with an emphasis on the recent ASTER trial as well as impending trials and diagnostic performance studies of EBUS-TBNA in sarcoidosis.
Keywords: Endobronchial ultrasound, lung cancer, mediastinal lymphadenopathy, mediastinoscopy, sarcoidosis, staging, transbronchial needle aspiration, pulmonologist, bronchoscopy, endoscopic
Reviews on Recent Clinical Trials
Title:Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
Volume: 8 Issue: 1
Author(s): Andrew Low and Andrew RL Medford
Affiliation:
Keywords: Endobronchial ultrasound, lung cancer, mediastinal lymphadenopathy, mediastinoscopy, sarcoidosis, staging, transbronchial needle aspiration, pulmonologist, bronchoscopy, endoscopic
Abstract: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an increasingly used technique by the interventional pulmonologist in lung cancer staging and diagnosis of both malignant and benign mediastinal lymphadenopathy amongst other applications. There are increasing data to support the use of EBUS-TBNA over mediastinoscopy as a first staging or diagnostic procedure in defined situations. In this review, the technique of EBUS-TBNA is briefly discussed with a more extended discussion around comparative studies of mediastinal staging techniques, with an emphasis on the recent ASTER trial as well as impending trials and diagnostic performance studies of EBUS-TBNA in sarcoidosis.
Export Options
About this article
Cite this article as:
Low Andrew and RL Medford Andrew, Endobronchial Ultrasound-guided Transbronchial Needle Aspiration, Reviews on Recent Clinical Trials 2013; 8(1) . https://dx.doi.org/10.2174/1574887111308010009
DOI https://dx.doi.org/10.2174/1574887111308010009 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma
Current Genomics Molecular Properties and Medical Applications of Peptide Nucleic Acids
Mini-Reviews in Medicinal Chemistry Autologous Adipose-Derived Regenerative Cells for Therapeutic Angiogenesis
Current Pharmaceutical Design High Therapeutic Potential for Systemic Delivery of a Liposomeconjugated Herpes Simplex Virus
Current Cancer Drug Targets Potential and Cytotoxicity of cis-Platinum Complex with Anti-tumor Activity in Combination Therapy
Recent Patents on Anti-Cancer Drug Discovery siRNA Delivery by Stimuli-Sensitive Nanocarriers
Current Pharmaceutical Design PET Imaging to Monitor Cancer Therapy
Current Pharmaceutical Biotechnology Pentapeptides as Minimal Functional Units in Cell Biology and Immunology
Current Protein & Peptide Science Gene Silencing in the Development of Personalized Cancer Treatment: The Targets, the Agents and the Delivery Systems
Current Gene Therapy Current Bioactive Azole-Containing Natural Products
Current Bioactive Compounds PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis
Anti-Cancer Agents in Medicinal Chemistry Cyclooxygenase-2 Inhibitors: A Painful Lesson
Cardiovascular & Hematological Disorders-Drug Targets Diaryl Urea: A Privileged Structure in Anticancer Agents
Current Medicinal Chemistry Marine Microbes-Derived Anti-Bacterial Agents
Mini-Reviews in Medicinal Chemistry Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
Current Cancer Drug Targets Biosurfactants as a Novel Additive in Pharmaceutical Formulations: Current Trends and Future Implications
Current Drug Metabolism Clinicopathological Significance of Long Non-Coding RNA <i>GHET1</i> in Human Cancers: A Meta-Analysis
Current Pharmaceutical Biotechnology Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 2. Structural Analogues and Derivatives
Current Drug Targets Molecular Targets in Malignant Pleural Mesothelioma Treatment
Current Drug Targets Chemical and Medicinal Versatility of Dithiocarbamates: An Overview
Mini-Reviews in Medicinal Chemistry